MLR

STRUCTURAL ANALYST NOTE: MLR (Miller Industries, Inc.)

Date: 2026-06-13 Current Price: $49.77

1. Structural Readiness

• Conservative Entry: Not Actionable. A conservative entry requires a confirmed breakout above the resistance level.
• Breakout Level: Not Defined. The resistance level required to confirm the setup is not provided.
• Extension: Not Defined. The distance from the breakout level to the current price is unknown.
• ATR Context: Current ATR is 2.8% (productive). This sits within the historical "sweet spot" (4-6% is high, but 2.8% indicates moderate volatility suitable for sizing, though below the "high" volatility threshold often associated with explosive breakouts).

2. Thesis Layer

• Thesis Classification: TACTICAL / SETUP-LED.
• Macro Thesis: None Named. As of 2026-06-13, there is no named secular thesis (e.g., "Global Infrastructure Boom" or "EV Transition") explicitly attached to this setup in the provided data.
• Judgment Criteria: The investment case must be judged strictly on the quality of the technical setup (which is currently forming/incomplete) and the strength of the underlying business fundamentals (backlog, margin recovery, expansion). Do not invent a macro narrative.

3. Business Fundamentals (As of 2026-06-13)

Miller Industries, Inc. is the world's largest manufacturer of towing and recovery equipment, producing bodies for car carriers and wreckers installed on third-party chassis. The company operates through a network of independent distributors across North America, Europe, and other global markets.

• Revenue & Backlog:
• Management expects full-year 2026 revenue between $850 million and $900 million (E2).
• The company began 2026 with over $150 million in military commitments, with production scheduled to begin in 2027 and revenue recognition primarily in 2028 and 2029 (E1).
• Following a period of inflated inventory in the distribution channel during fiscal 2025, management expects a return to a "steady flow" of deliveries in fiscal 2026 as channel inventory normalizes (E21, E22).
• Margins & Pricing:
• Management expects gross margins to return to historical levels in the mid-13% range for full year 2026, driven by a product mix shift back toward bodies and chassis (E4).
• A 3% price increase on all manufactured products invoiced after July 31, 2026, has been announced (E10). Additionally, an updated pricing structure for all manufactured products begins August 1, 2026 (E3).
• Expansion & Capacity:
• The Board authorized a $100 million plant expansion at the Ooltewah, TN facility in March 2026. The building project is expected to commence in late 2026, with the facility becoming production-ready by late 2027 (E5, E9, E19).
• The acquisition of Omars S.p.A. (completed Dec 2, 2025) is contributing to growth, adding $7.6 million in sales for the Q1 2026 quarter alone and expanding the European footprint (E14, E15).
• An EUR 8 million expansion at the Jige facility in France is on track for completion by mid-2027 (E8).
• Financial Outlook:
• Forward consensus EPS is projected at $1.815 for FY1 and $3.14 for FY2 (E30).
• Net foreign sales increased 25.1% year-over-year in Q1 2026, driven by the Omars acquisition and international demand (E14).

4. Archetype and Conviction

• Archetype: Growth Leader (with elements of Margin Inflector).
• *Fit:* The company is transitioning from a period of inventory normalization (2025) to a growth phase driven by new capacity (Ooltewah expansion), international acquisitions (Omars), and a recovering military backlog. The explicit guidance to return margins to mid-13% and the aggressive capex ($100M) signal a focus on scaling operations and improving profitability.
• Valuation Context:
• The financial spine indicates a significant earnings growth trajectory, with FY2 EPS ($3.14) nearly double FY1 ($1.815). This suggests the market is pricing in a substantial earnings expansion.
• Conviction Stack:
• Thesis Strength: Moderate. Lacks a named macro thesis, relying on company-specific execution.
• Evidence Quality: High. Multiple primary sources (earnings transcripts, SEC filings) confirm the backlog, margin targets, and capex plans.
• Structural Quality: Incomplete. The setup is "Forming." While the fundamentals are strong, the technical setup has not fired. The "Forming" state carries a ~69% historical breakout probability but is not a confirmed signal.
• Rerating Potential: High, contingent on the successful execution of the Ooltewah expansion and the realization of the military backlog in 2027-2028.

5. Invalidations, Strengths, and Gaps

• What Would Invalidate:
• Management guidance revision indicating a delay in the Ooltewah expansion or a failure to achieve the mid-13% margin target.
• A significant deterioration in the military backlog or a cancellation of the Omars integration benefits.
• What Would Strengthen:
• A confirmed breakout above the resistance level (price action confirmation).
• Further updates confirming the "steady flow" of deliveries and the successful ramp-up of the new Ooltewah facility ahead of schedule.
• Continued strong growth in foreign sales beyond the Omars contribution.
• Gaps in Evidence:
• ATR at Breakout: The structural quality ATR at the time of a potential breakout is not provided.
• Sector/Industry Classification: The specific sector and industry labels are not provided in the data.
• Current Extension: The distance of the current price from the breakout level is unknown.

PRIVATE ANALYST CALL

Judgment: Speculative Confidence: medium Key evidence: Management guidance for $850M-$900M revenue in 2026 and mid-13% gross margins; $150M military backlog with 2027-2028 revenue recognition; $100M Ooltewah expansion authorized for late 2026 start. Sizing hint: Position size should be conservative given the "Forming" status and lack of confirmed technical entry; treat as a watch-list candidate pending breakout confirmation. Expected path: Price likely consolidates or grinds higher as management executes the Ooltewah expansion and Omars integration, with a potential breakout if the $100M capex and margin targets are met. Expected horizon: 6 to 12 months for the setup to resolve into a confirmed breakout or invalidation.